Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
Arq. bras. med. vet. zootec. (Online) ; 73(2): 361-366, Mar.-Apr. 2021. tab, ilus
Article in English | LILACS, VETINDEX | ID: biblio-1248924

ABSTRACT

We investigated the local and systemic effects of hyperbaric oxygen therapy in BALB/C mice, exposed to two different exposure times, under 2.4 atmosphere (ATM). Fifteen animals were divided into three groups (GI, GII and Control) and underwent a surgical excision of a skin fragment of approximately one square centimeter of the dorsal region. The wounds were treated and monitored for 21 days. In the control group, the wound was cleaned once a day with sterile 0.9% NaCl solution. GI and GII mice were submitted to daily hyperbaric oxygen therapy of 30 or 60minutes sessions, respectively. The wounds were photographed every three days and their surfaces were analyzed by an image analyzer. At 21 days, all animals were euthanatized for histopathological analysis of the skin, lungs and liver in order to identify eventual alterations in wound healing or in the analyzed organs. Animals belonging to GI showed a faster skin wound healing in comparison to the other groups. Animals from GII, however, showed a delayed wound healing process and exhibited lung and microcirculatory alterations. These findings allow us to conclude that the exposure time to the oxygen in hyperbaric environment is crucial and can help or disturb skin wound healing or even be deleterious to other organs.(AU)


Investigaram-se os efeitos locais e sistêmicos da oxigenoterapia hiperbárica em camundongos BALB / C, submetidos a dois tempos de exposição diferentes, sob atmosfera 2,4 (ATM). Quinze animais foram divididos em três grupos (GI, GII e controle) e submetidos à excisão cirúrgica de fragmento de pele de aproximadamente um centímetro quadrado da região dorsal. As feridas foram tratadas e acompanhadas por 21 dias. No grupo controle, a ferida foi limpa uma vez ao dia, com solução estéril de NaCl 0,9%. Camundongos GI e GII foram submetidos à oxigenoterapia hiperbárica diária de 30 ou 60 minutos de sessões, respectivamente. As feridas foram fotografadas a cada três dias, e suas superfícies analisadas por um analisador de imagens. Aos 21 dias, todos os animais foram submetidos à eutanásia para análise histopatológica da pele, do pulmão e do fígado, em busca de eventuais alterações na cicatrização da ferida ou nos órgãos analisados. Animais pertencentes ao GI apresentaram cicatrização mais rápida de feridas cutâneas em comparação aos outros grupos. Já os animais do GII apresentaram retardo na cicatrização da ferida e alterações pulmonares e microcirculatórias. Esses achados permitem concluir que o tempo de exposição ao oxigênio em ambiente hiperbárico é fundamental e pode auxiliar ou atrapalhar a cicatrização de feridas cutâneas ou mesmo ser deletério para outros órgãos.(AU)


Subject(s)
Animals , Mice , Degloving Injuries/therapy , Hyperbaric Oxygenation/methods , Hyperbaric Oxygenation/veterinary , Wound Healing
2.
Rev. cuba. med. mil ; 49(1): e333, ene.-mar. 2020. fig
Article in Spanish | LILACS, CUMED | ID: biblio-1126692

ABSTRACT

Introducción: La gangrena de Fournier es una enfermedad infecciosa caracterizada por una fascitis necrotizante de evolución fulminante que afecta a la región perineal, genital o perianal, con una rápida progresión y alta letalidad. Objetivo: Describir la sintomatología del paciente y buena evolución, a pesar de varios factores de mal pronóstico. Caso clínico: Se trata de un paciente masculino de 77 años de edad, diabético e hipertenso, remitido a cuidados intensivos, desde el servicio de Urología, con el diagnóstico de gangrena de Fournier, descontrol metabólico y agudización de su enfermedad renal crónica. Conclusiones: Con el tratamiento médico quirúrgico intensivo y la utilización de oxigenación hiperbárica, tuvo una evolución favorable, hasta su egreso(AU)


Introduction: Fournier gangrene is an infectious disease characterized by a necrotizing fascitis of fulminant evolution that affects the perineal, genital or perianal region, with rapid progression and high lethality. Objective: To describe the patient symptomatology and good evolution, despite several factors of poor prognosis. Clinical case: 77-year-old male patient, diabetic and hypertensive, referred to intensive care, from the urology department, with the diagnosis of Fournier gangrene, metabolic decontrol and exacerbation of chronic kidney disease. Conclusions: With intensive surgical and medical treatment and the use of hyperbaric oxygenation, he had a favorable evolution, until his discharge(AU)


Subject(s)
Humans , Male , Aged , Communicable Diseases , Fournier Gangrene , Fasciitis, Necrotizing/diagnosis , Critical Care/methods , Genitalia , Hyperbaric Oxygenation/methods
3.
Clinics ; 75: e1656, 2020. graf
Article in English | LILACS | ID: biblio-1133444

ABSTRACT

OBJECTIVES: Mesenchymal stem cells (MSCs) are potentially ideal for type 2 diabetes treatment, owing to their multidirectional differentiation ability and immunomodulatory properties. Here we investigated whether the stem cells from human exfoliated deciduous teeth (SHED) in combination with hyperbaric oxygen (HBO) could treat type 2 diabetic rats, and explored the underlying mechanism. METHODS: SD rats were used to generate a type 2 diabetes model, which received stem cell therapy, HBO therapy, or both together. Before and after treatment, body weight, blood glucose, and serum insulin, blood lipid, pro-inflammatory cytokines (tumor necrosis factor-alpha and interleukin-6), and urinary proteins were measured and compared. After 6 weeks, rats were sacrificed and their organs were subjected to hematoxylin and eosin staining and immunofluorescence staining for insulin and glucagon; apoptosis and proliferation were analyzed in islet cells. Structural changes in islets were observed under an electron microscope. Expression levels of Pdx1, Ngn3, and Pax4 mRNAs in the pancreas were assessed by real-time quantitative polymerase chain reaction (RT-qPCR). RESULTS: In comparison with diabetic mice, those treated with the combination or SHE therapy showed decreased blood glucose, insulin resistance, serum lipids, and pro-inflammatory cytokines and increased body weight and serum insulin. The morphology and structure of pancreatic islets improved, as evident from an increase in insulin-positive cells and a decrease in glucagon-positive cells. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining of islet cells revealed the decreased apoptosis index, while Ki67 and proliferating cell nuclear antigen staining showed increased proliferation index. Pancreatic expression of Pdx1, Ngn3, and Pax4 was upregulated. CONCLUSION: SHED combined with HBO therapy was effective for treating type 2 diabetic rats. The underlying mechanism may involve SHED-mediated increase in the proliferation and trans-differentiation of islet β-cells and decrease in pro-inflammatory cytokines and apoptosis of islets.


Subject(s)
Humans , Animals , Male , Mice , Rats , Mesenchymal Stem Cell Transplantation , Diabetes Mellitus, Experimental/therapy , Diabetes Mellitus, Type 2/therapy , Insulin-Secreting Cells , Hyperbaric Oxygenation/methods , Stem Cells , Tooth, Deciduous , China , Rats, Sprague-Dawley , Diabetes Mellitus, Type 2/chemically induced , Mesenchymal Stem Cells , Insulin
4.
Rev. Hosp. Ital. B. Aires (2004) ; 39(3): 81-85, sept. 2019.
Article in Spanish | LILACS | ID: biblio-1048229

ABSTRACT

El dolor crónico constituye un reto terapéutico especial. Se presenta una revisión narrativa sobre el papel del tratamiento de oxigenación hiperbárica (TOHB) en el tratamiento del dolor neuropático, y sus aplicaciones en dolor crónico, síndromes neurosensitivos disfuncionales y oncodolor. El conocimiento de las indicaciones de TOHB en algiología y su aplicación en la práctica médica puede contribuir a mejorar la calidad de vida del paciente. (AU)


Chronic pain represents a special therapeutic challenge. We present a narrative review on the role of Hyperbaric Oxygen Therapy (HBOT) in the treatment of neuropathic pain, and its applications in chronic pain, dysfunctional neurosensitive syndromes and oncological pain. The knowledge of the indications of HBOT in algiology and its application in medical practice can contribute to improve the quality of life of the patient. (AU)


Subject(s)
Chronic Pain/therapy , Hyperbaric Oxygenation/methods , Phantom Limb/therapy , Quality of Life , Reflex Sympathetic Dystrophy/therapy , Vascular Headaches/therapy , Brain Diseases/therapy , Facial Pain/therapy , Fibromyalgia/therapy , Causalgia/therapy , Diabetic Neuropathies/therapy , Edema/therapy , Neuralgia, Postherpetic/therapy , Chronic Pain/epidemiology , Cancer Pain/therapy , Hyperbaric Oxygenation/trends , Analgesia/methods , Inflammation/therapy , Neuralgia/therapy
5.
Rev. Asoc. Méd. Argent ; 131(4): 12-20, Dic. 2018. ilus, graf, tab
Article in Spanish | LILACS | ID: biblio-1009724

ABSTRACT

El uso clínico de la terapia de oxigenación hiperbárica (TOHB) consiste en respirar oxígeno en una concentración cercana al 100% en una cámara presurizada al menos a 1,4 atmósferas absolutas (atm). TOHB actúa produciendo hiperoxia y especies reactivas del oxígeno que desencadenan mecanismos bioquímicos variados. Se presenta una revisión de todas las nuevas aplicaciones emergentes de TOHB en varias especialidades médicas debido a que alcanza beneficios en la cicatrización de heridas, enfermedades inflamatorias y con componente neurológico o isquémico. Las nuevas cámaras realizan el tratamiento a presiones más seguras y con la misma eficiencia demostrada por métodos matemáticos y bioquímicos. El Grupo BioBárica Clinical Research presenta la estadística de las indicaciones en 559 pacientes tratados con estas cámaras en algunos centros médicos y las especialidades médicas implicadas. El uso de TOHB a media presión está en emergencia y podría proveer a futuro evidencia de su efectividad en otras especialidades médicas. (AU)


The clinical use of Hyperbaric Oxygen Therapy (HBOT) consists in breathing oxygen (O2) near to 100% in a pressurized chamber of at least at 1.4 absolute atmospheres (ATA). HBOT acts producing both hyperoxia and reactive oxygen species (ROS) and triggers others biochemical events. The BioBarica Clinical Research Group is developing clinical evidence in diverse pathologies because of accessibility and safety of the new Revitalair hyperbaric oxygen chamber. Because of working at "mild pressure", HBOT performed by these chamber are safer demonstrated by mathematical and biochemical methods. The BioBarica Clinical Research Group presents the statistics of the indications in 559 patients treated with these cameras in some medical centers and the medical specialties involved. Their accessibility to the physicians would become mild pressure HBOT used more frequently proving its effectiveness in other clinical specialties. (AU)


Subject(s)
Humans , Treatment Outcome , Contraindications, Procedure , Hyperbaric Oxygenation/instrumentation , Hyperbaric Oxygenation/methods , Wounds and Injuries/therapy , Carbon Monoxide Poisoning/therapy , Rheumatic Diseases/therapy , Diabetic Foot/therapy , Physical Conditioning, Human/methods , Neoplasms/therapy
6.
Acta cir. bras ; 33(9): 824-833, Sept. 2018. tab, graf
Article in English | LILACS | ID: biblio-973497

ABSTRACT

Abstract Purpose: To evaluate the effects of hyperbaric oxygenation on prevention of adhesions in the abdominal cavity after laparotomy. Methods: Fifty four rats underwent laparotomy; stitches were made in the four quadrant parietal peritoneum and abdominal cavity closure. Animals were divided into three groups: 1 - control; 2 - subjected to high pressures and oxygenation; 3 - subjected to 100% hyperbaric oxygenation. The animals in groups 2 and 3 were daily submitted to oxygenation hyperbaric chamber after surgery. On the seventh day another laparotomy, registration of procedure, assessment of adhesions and biopsies of the peritoneum were held. Professionals analyzed the videos and the biopsies. Results: Peritoneal cavity adhesions occurred in animals of three groups with no difference between them. In Group 3, the adhesions presented more fragile and vascular proliferation more pronounced, and there was no difference in comparison with the first and second groups. However, there was no significant difference in the evaluation of these parameters between the animals in groups 1 and 2. Conclusions: Postoperative hyperbaric oxygenation in rats submitted to laparotomy did not alter the frequency, but reduced the density of adhesions in the peritoneal cavity and promoted vascular proliferation. The change in atmospheric pressure alone had no influence on the results.


Subject(s)
Animals , Rats , Peritoneal Cavity/surgery , Postoperative Complications/prevention & control , Tissue Adhesions/prevention & control , Hyperbaric Oxygenation/methods , Peritoneal Cavity/pathology , Rats, Wistar , Disease Models, Animal , Laparotomy
7.
Acta cir. bras ; 33(5): 462-471, May 2018. tab, graf
Article in English | LILACS | ID: biblio-949341

ABSTRACT

Abstract Purpose: To evaluate the effect of hyperbaric oxygenation (HBO) on the expression of the genes antioxidant glutathione peroxidase 4 (Gpx4) and lactoperoxidase (Lpo) in the lung of mice subjected to intestinal ischemia and reperfusion (IIR). Methods: Control group (CG) in which were subjected to anesthesia, laparotomy and observation for 120 minutes; an ischemia and reperfusion group (IRG) subjected to anesthesia, laparotomy, small bowel ischemia for 60 minutes and reperfusion for 60 minutes; and three groups treated with HBO during ischemia (HBOG + I), during reperfusion (HBOG + R) and during ischemia and reperfusion (HBOG + IR). Studied 84 genes of oxidative stress by the method (RT-qPCR). Genes with expression levels three times below or above the threshold cycle were considered significantly hypoexpressed or hyperexpressed, respectively (Student's t-test p<0.05). Results: Gpx4 and Lpo were hiperexpressed on IRG, showing a correlation with these genes with lung oxidative stress. Treated with HBO, there was a significant reduction on genic expression on HBOG+I. Conclusion: Hyperbaric oxygenation showed to be associated with decreased expression of these antioxidant genes, suggesting a beneficial effect on the mechanism of pulmonary oxidative stress whenever applied during the ischemia.


Subject(s)
Animals , Rats , Reperfusion Injury/metabolism , Oxidative Stress/genetics , Glutathione Peroxidase/metabolism , Hyperbaric Oxygenation/methods , Lactoperoxidase/genetics , Lung/metabolism , Oxidative Stress/drug effects , Disease Models, Animal , Intestines/blood supply , Ischemia/metabolism , Antioxidants/metabolism , Antioxidants/pharmacology
8.
Acta cir. bras ; 33(4): 341-353, Apr. 2018. graf
Article in English | LILACS | ID: biblio-886284

ABSTRACT

Abstract Purpose: To investigate the effect of hyperbaric oxygen therapy (HBOT) on traumatic brain injury (TBI) outcome. Methods: The modified Marmarou's weight drop device was used to generate non-lethal moderate TBI rat model, and further developed in vitro astrocytes culturing system. Then, we analyzed the expression changes of interested genes and protein by quantitative PCR and western blot. Results: Multiple HBO treatments significantly reduced the expression of apoptosis promoting genes, such as c-fos, c-jun, Bax and weakened the activation of Caspase-3 in model rats. On the contrary, HBOT alleviated the decrease of anti-apoptosis gene Bcl-2 and promoted the expression of neurotrophic factors (NTFs), such as NGF, BDNF, GDNF and NT-3 in vivo. As a consequent, the neuropathogenesis was remarkably relied with HBOT. Astrocytes from TBI brain or those cultured with 21% O2 density expressed higher NTFs than that of corresponding controls, from sham brain and cultured with 7% O2, respectively. The NTFs expression was the highest in astrocytes form TBI brain and cultured with 21% O2, suggesting a synergistic effect existed between TBI and the following HBO treatment in astrocytes. Conclusion: Our findings provided evidence for the clinical usage of HBO treating brain damages.


Subject(s)
Animals , Male , Brain Injuries, Traumatic/therapy , Hyperbaric Oxygenation/methods , Time Factors , Blotting, Western , Astrocytes/physiology , Reproducibility of Results , Treatment Outcome , Rats, Sprague-Dawley , Apoptosis/physiology , Disease Models, Animal , Caspase 3/physiology , Real-Time Polymerase Chain Reaction , Brain Injuries, Traumatic/pathology , Nerve Growth Factors/analysis
9.
J. appl. oral sci ; 26: e20180083, 2018. tab, graf
Article in English | LILACS, BBO | ID: biblio-954498

ABSTRACT

Abstract Objective To evaluate whether hyperbaric oxygen (HBO) treatment has a favorable effect on implant osseointegration in diabetic rabbits. Material and Methods An experimental diabetes model was induced in 32 New Zealand rabbits through IV injection of alloxan. After the state of diabetes had been confirmed, one dental implant was placed in the metaphysical region of each animal's tibia. After the implants' placements, the animals were divided into two groups. Half of the animals underwent HBO treatment, while the other group did not receive HBO treatment and served as the control group. The animals were euthanized at the 4th and 8th weeks. The osseointegration of the implants were compared by histomorphometry and resonance frequency analysis (RFA). Results The Bone Implant Contact (BIC) values were significantly higher in the HBO group than in the control group at the 4th week. There was no difference in the BIC values between the groups at the 8th week. There was no significant difference in the RFA scores between the groups both at the 4th and 8th weeks after the operation. Conclusion Histomorphometry findings suggest that HBO has positive effect on implant osseointegration in the early healing period in diabetic rabbits. However, implant stability is not affected by HBO treatment.


Subject(s)
Animals , Male , Osseointegration/physiology , Dental Implantation, Endosseous/methods , Diabetes Mellitus, Experimental/physiopathology , Hyperbaric Oxygenation/methods , Rabbits , Tibia/surgery , Time Factors , Wound Healing , Bone Regeneration/physiology , Reproducibility of Results , Treatment Outcome , Alloxan , Bone-Implant Interface/physiology
10.
Acta cir. bras ; 32(11): 913-923, Nov. 2017. tab, graf
Article in English | LILACS | ID: biblio-886181

ABSTRACT

Abstract Purpose: To investigate the effects of hyperbaric oxygenation (HBO) on intestinal ischemia and reperfusion (IR) injury, we evaluated the expression of 84 genes related to oxidative stress and the antioxidant response in mouse hearts. Methods: Four groups were subjected to 60 minutes of intestinal ischemia followed by 60 minutes of reperfusion: IRG, ischemia and reperfusion group without HBO; HBO-IG, which received HBO during ischemia; HBO-RG, which received HBO during reperfusion; and HBO-IRG, which received HBO during ischemia and reperfusion. The control group (CG) underwent anesthesia and laparotomy and was observed for 120 minutes. The (RT-qPCR) method was applied. Genes with expression levels three times below or above the threshold cycle were considered significantly hypoexpressed or hyperexpressed, respectively (Student's t-test p<0.05). Results: Eight genes (9.52%) were hyperexpressed in the IRG. When the HBO groups were compared to the IRG, we found a decrease in the expression of eight genes in the HBO-IG, five genes in the HBO-RG, and seven genes in the HBO-IRG. Conclusion: The reduction in the expression of genes related to oxidative stress and antioxidant defense following HBO in mouse hearts resulting from intestinal IR injury was more favorable during the ischemic period than during the reperfusion period.


Subject(s)
Animals , Male , Mice , Reperfusion Injury/prevention & control , Gene Expression , Oxidative Stress/genetics , Hyperbaric Oxygenation/methods , Intestines/blood supply , Reperfusion Injury/metabolism , Polymerase Chain Reaction , Oxidative Stress/drug effects , NADPH Oxidases/metabolism , Coronary Vessels/enzymology , Disease Models, Animal , Heart , Heart Diseases , Ischemia/metabolism , Mice, Inbred C57BL , Antioxidants/metabolism , Antioxidants/pharmacology
11.
Braz. j. otorhinolaryngol. (Impr.) ; 83(4): 457-463, July-Aug. 2017. tab
Article in English | LILACS | ID: biblio-889284

ABSTRACT

Abstract Introduction: It is difficult to evaluate the effect of drugs clinically used for idiopathic sudden sensorineural hearing loss, mainly because its underlying mechanism remains unknown. Objective: This study assessed the efficacy of hyperbaric oxygen therapy or ozone therapy in the treatment of idiopathic sudden sensorineural hearing loss, when either therapy was included with steroid treatment. Methods: A retrospective analysis examined 106 patients with idiopathic sudden sensorineural hearing loss seen between January 2010 and June 2012. Those with an identified etiology were excluded. The patients were divided into three treatment groups: oral steroid only (n = 65), oral steroid + hyperbaric oxygen (n = 26), and oral steroid + ozone (n = 17). Treatment success was assessed using Siegel criteria and mean gains using pre- and post-treatment audiograms. Results: The highest response rate to treatment was observed in the oral steroid + ozone therapy group (82.4%), followed by the oral steroid + hyperbaric oxygen (61.5%), and oral steroid groups (50.8%). There were no significant differences in the response to treatment between the oral steroid and oral steroid + hyperbaric oxygen groups (p < 0.355). The oral steroid + ozone group showed a significantly higher response rate to treatment than the oral steroid group (p = 0.019). There were no significant differences between the oral steroid + hyperbaric oxygen and oral steroid + ozone groups (p = 0.146). Conclusion: The efficiency of steroid treatment in patients with severe hearing loss was low. It was statistically ascertained that adding hyperbaric oxygen or ozone therapy to the treatment contributed significantly to treatment success.


Resumo Introdução: É difícil avaliar o efeito dos fármacos clinicamente usados na surdez súbita idiopática, principalmente porque o seu mecanismo subjacente se mantém desconhecido. Objetivo: Avaliar a eficácia da oxigenoterapia hiperbárica ou ozonioterapia no tratamento de surdez súbita, quando uma ou outra terapia é incluída no tratamento com esteroides. Método: Uma análise retrospectiva examinou 106 pacientes com surdez súbita atendidos entre janeiro de 2010 e junho de 2012. Aqueles com uma etiologia identificada foram excluídos. Os pacientes foram divididos em três grupos de tratamento: apenas esteroide oral (n = 65), esteroide por via oral + oxigenoterapia hiperbárica (n = 26) e esteroides por via oral + ozônio (n = 17). O sucesso do tratamento foi avaliado com critérios de Siegel e os ganhos médios com audiogramas pré e pós-tratamento. Resultados: A taxa de resposta mais elevada para o tratamento foi observada no grupo de esteroide + ozonioterapia (82,4%), seguida por grupos de esteroide oral + oxigenoterapia hiperbárica (61,5%) e esteroide oral (50,8%). Não houve diferenças significantes na resposta ao tratamento entre os grupos de esteroide oral e esteroides + oxigenoterapia hiperbárica (p < 0,355). O grupo de esteroide oral + ozônio apresentou uma taxa de resposta significantemente mais elevada ao tratamento do que o grupo de esteroide oral (p = 0,019). Não houve diferenças significantes entre os grupos de esteroide oral + oxigenoterapia hiperbárica e esteroide oral + ozônio (p = 0,146). Conclusão: A eficiência do tratamento com esteroides em pacientes com perda auditiva grave foi baixa. Verificou-se estatisticamente que a adição de oxigenoterapia hiperbárica ou ozonioterapia ao tratamento contribuiu significantemente para o sucesso do tratamento.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Ozone/administration & dosage , Steroids/administration & dosage , Hearing Loss, Sudden/therapy , Hyperbaric Oxygenation/methods , Audiometry , Severity of Illness Index , Retrospective Studies , Treatment Outcome , Combined Modality Therapy
12.
Int. braz. j. urol ; 43(3): 489-495, May.-June 2017. tab
Article in English | LILACS | ID: biblio-840847

ABSTRACT

ABSTRACT Purpose To examine the safety and efficacy of hyperbaric oxygen as the primary and sole treatment for severe radiation-induced haemorrhagic cystitis. Materials and methods Hyperbaric oxygen was prospectively applied as primary treatment in 38 patients with severe radiation cystitis. Our primary endpoint was the incidence of complete and partial response to treatment, while the secondary endpoints included the duration of response, the correlation of treatment success-rate to the interval between the onset of haematuria and initiation of therapy, blood transfusion need and total radiation dose, the number of sessions to success, the avoidance of surgery and the overall survival. Results All patients completed therapy without complications with a mean follow-up of 29.33 months. Median number of sessions needed was 33. Complete and partial response rate was 86.8% and 13.2%, respectively. All 33 patients with complete response received therapy within 6 months of the haematuria onset. One patient needed cystectomy, while 33 patients were alive at the end of follow-up. Conclusions Our study suggests the early primary use of hyperbaric oxygen for radiation-induced severe cystitis as an effective and safe treatment option.


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Radiation Injuries , Cystitis/therapy , Hyperbaric Oxygenation/methods , Radiation Injuries/complications , Severity of Illness Index , Cystectomy , Prospective Studies , Treatment Outcome , Cystitis/etiology , Middle Aged
13.
Rev. cuba. angiol. cir. vasc ; 18(1): 71-81, ene.-jun. 2017. ilus, tab
Article in Spanish | LILACS | ID: biblio-844807

ABSTRACT

Introducción: Las úlceras del pie diabético en estadio 4 y 5 de Wagner constituyen lesiones crónicas avanzadas con deterioro vascular, de pronóstico reservado y predicen riesgo de amputación superior a 90 por ciento. Objetivo: Describir la evolución del pie diabético en los grados 4 y 5 de la clasificación de Wagner. Métodos: Estudio descriptivo, retrospectivo, en el Hospital "Manuel Fajardo" desde junio 2011 hasta mayo 2016. La muestra estuvo constituida por 46 pacientes; se les aplicó Heberprot-P® y se asoció cámara hiperbárica al pie diabético complicado. Las variables estudiadas fueron: edad, sexo, factores de riesgo, tiempo de evolución de la diabetes mellitus, nivel anatómico de ausencias de pulsos, escala de Wagner, evolución de la lesión, cámara hiperbárica, porcentaje de granulación y semanas de tratamiento. Resultados: Habían 22 (47,8 por ciento) pacientes mayores de 67 años de edad, el sexo masculino fue el más afectado 38 (82,6 por ciento); la hipertensión arterial y el hábito de fumar fueron los factores de riesgo más frecuentes; 32 pacientes con más de 20 años de evolución de la diabetes mellitus. La ausencia de pulso poplíteo se observó en 37 pacientes. Con pie diabético en estadio 4 y 5 de Wagner hubo 31 (67,3 por ciento) y 15 (32,6 por ciento) pacientes respectivamente; 24 mostraron infección sobreañadida, de ellos 20 usaron cámara hiperbárica, 7 fracasos al tratamiento, 3 amputaciones infracondilia y 4 supracondilia. Epitelizaron al 100 por ciento 33 pacientes y 6 evolucionan satisfactoriamente. Conclusiones: El pie diabético en estadios terminales evoluciona favorablemente con Heberprot-P® y cámara hiperbárica(AU)


Introduction: The diabetic foot ulcers classified as 4 and 5 grades in Wagner´s classification scale are advanced chronic vascular lesions with a worse prognosis and they predict a risk of amputation over 90 percent. Objectives: To describe the evolution of the 4th and 5th grade diabetic foot in the Wagner classification scale. Methods: A retrospective and descriptive study was conducted in a sample of 46 patients at ¨Manuel Fajardo¨ hospital from June 2011 to May 2016. These patients were treated with Heberprot-P® and hyperbaric chamber therapy was added to manage complicated diabetic foot. The study variables were age, gender, risk factor, length of time with diabetes mellitus, anatomical level of pulse absence, Wagner's classification scale, ulcer evolution, hyperbaric chamber, granulation percentage and number of weeks of treatment. Results: There were 22 (47.8 percent) patients aged over 67 years, males were the most affected with 38 individuals (82.6 percent), hypertension and smoking were the most frequent risk factors and 32 patients had suffered from diabetes for more than 20 years. The popliteal pulse was not found in 37 patients. Thirty one (67.3 percent) and 15 (32.6 percent) patients showed diabetic foot graded 4 and 5, respectively. Twenty four patients showed added infection, 20 of them were treated with hyperbaric chamber, 7 patients did not succeed in treatment, 4 underwent supracondylar and 3 infracondylar amputations. Thirty three patients reached 100 percent epithelization and 6 recovered satisfactorily. Conclusions: The diabetic foot classified as terminal staging may present favorable evolution with the use of Heberprot-P® and hyperbaric chamber(AU)


Subject(s)
Diabetes Mellitus/therapy , Diabetic Foot/rehabilitation , Hyperbaric Oxygenation/methods , Epidemiology, Descriptive , Retrospective Studies
14.
Int. j. odontostomatol. (Print) ; 10(3): 409-417, dic. 2016. ilus
Article in English | LILACS | ID: biblio-840989

ABSTRACT

Extensive resection of tumor often results in bone and soft tissue defects that cause functional and esthetic consequences. The reconstructive surgery is extremely important for the rehabilitation of these patients. The purpose of this study is to report on the use of Hyperbaric Oxygen therapy (HBO) in the case of a large ameloblastoma treated with segmental resection and reconstructed immediately with nonvascularized bone graft (NVBGs) from iliac crest. A 41-year-old woman was referred to our department because of paresthesia of the inferior alveolar nerve and history of swelling in the molar and ramus region of the left mandible. Panoramic radiograph depicting well-defined multilocular radiolucency extending from second pre-molar region to the left ramus region. An incisional biopsy confirms the diagnosis of solid ameloblastoma. The treatment of choice was segmental mandibular resection and immediate mandibular reconstruction using NVBGs from iliac crest, followed by removal of internal fixation and placement of dental implants with immediate loading. The patient received preoperative HBO (a 90-min session at 2.2-2.4 atmospheres, five times per week for two weeks, for a total of up to 10 sessions). Postoperative HBO (10 further 90-min sessions) was administered within 2weeks. The patient received rehabilitation with a mandibular implant-supported fixed complete dental prosthesis. The present study showed successful management of mandibular ameloblastoma that associated extensive surgery, immediate reconstruction with NVBGs from iliac crest, hyperbaric oxygen therapy and dental implants. These combined procedures allowed removal of lesion and reestablishment of mandibular contour and function.


La resección extensa de un tumor a menudo da lugar a defectos del hueso y de los tejidos blandos, que causan consecuencias funcionales y estéticas. La cirugía reconstructiva es extremadamente importante para la rehabilitación de estos pacientes. El propósito de este estudio fue informar sobre el uso de la terapia de oxígeno hiperbárico (HBO) en un caso de un ameloblastoma de gran tamaño, tratado con resección segmentaria y reconstruido inmediatamente con injerto óseo no vascularizado (IONV) de la cresta ilíaca. Una mujer de 41 años fue derivada a nuestro servicio por parestesia del nervio alveolar inferior e historia de hinchazón en la región molar y ramina de la mandíbula izquierda. Radiografía panorámica que muestra una radiolucencia multilocular bien definida que se extiende desde la segunda región pre-molar hasta la región de la rama izquierda. Una biopsia incisional confirma el diagnóstico de ameloblastoma sólido. El tratamiento de elección fue la resección mandibular segmentaria y la reconstrucción mandibular inmediata mediante IONV de cresta ilíaca, seguido de la eliminación de la fijación interna y la colocación de implantes dentales con carga inmediata. La paciente recibió OHB preoperatoria (una sesión de 90 minutos a 2.2-2.4 atmósferas, cinco veces por semana durante dos semanas, para un total de hasta 10 sesiones). La OHB postoperatoria (10 sesiones adicionales de 90 minutos) se administró en 2 semanas. La paciente recibió rehabilitación con una prótesis dental fija con implante mandibular. El presente estudio mostró un manejo exitoso del ameloblastoma mandibular asociado a una cirugía extensa, reconstrucción inmediata con IONV de cresta ilíaca, oxigenoterapia hiperbárica e implantes dentales. Estos procedimientos combinados permitieron la extirpación de la lesión y el restablecimiento del contorno y la función mandibular.


Subject(s)
Humans , Female , Adult , Ameloblastoma/surgery , Bone Transplantation/methods , Hyperbaric Oxygenation/methods , Mandibular Neoplasms/surgery , Ameloblastoma/diagnostic imaging , Mandibular Neoplasms/diagnostic imaging , Mandibular Reconstruction , Oral Surgical Procedures/methods , Radiography, Panoramic
15.
Braz. j. med. biol. res ; 49(5): e5187, 2016. tab, graf
Article in English | LILACS | ID: biblio-951674

ABSTRACT

The timing and mechanisms of protection by hyperbaric oxygenation (HBO) in hypoxic-ischemic brain damage (HIBD) have only been partially elucidated. We monitored the effect of HBO on the mitochondrial function of neuronal cells in the cerebral cortex of neonatal rats after HIBD. Neonatal Sprague-Dawley rats (total of 360 of both genders) were randomly divided into normal control, HIBD, and HIBD+HBO groups. The HBO treatment began immediately after hypoxia-ischemia (HI) and continued once a day for 7 consecutive days. Animals were euthanized 0, 2, 4, 6, and 12 h post-HI to monitor the changes in mitochondrial membrane potential (ΔΨm) occurring soon after a single dose of HBO treatment, as well as 2, 3, 4, 5, 6, and 7 days post-HI to study ΔΨm changes after a series of HBO treatments. Fluctuations in ΔΨm were observed in the ipsilateral cortex in both HIBD and HIBD+HBO groups. Within 2 to 12 h after HI insult, the ΔΨm of the HIBD and HIBD+HBO groups recovered to some extent. A secondary drop in ΔΨm was observed in both groups during the 1-4 days post-HI period, but was more severe in the HIBD+HBO group. There was a secondary recovery of ΔΨm observed in the HIBD+HBO group, but not in the HIBD group, during the 5-7 days period after HI insult. HBO therapy may not lead to improvement of neural cell mitochondrial function in the cerebral cortex in the early stage post-HI, but may improve it in the sub-acute stage post-HI.


Subject(s)
Animals , Male , Female , Rats , Cerebral Cortex/pathology , Hypoxia-Ischemia, Brain/therapy , Hyperbaric Oxygenation/methods , Mitochondria/pathology , Neurons/pathology , Time Factors , Random Allocation , Cerebral Cortex/physiopathology , Rats, Sprague-Dawley , Hypoxia-Ischemia, Brain/physiopathology , Hypoxia-Ischemia, Brain/pathology , Disease Models, Animal , Animals, Newborn , Mitochondria/physiology , Neurons/physiology
16.
Acta cir. bras ; 31(supl.1): 19-23, 2016. tab, graf
Article in English | LILACS | ID: lil-779764

ABSTRACT

PURPOSE: To investigate de adjunctive effect of Hyperbaric Oxygen Therapy in a group of patients with refractory Crohn's disease. METHODS: A total of 29 subjects with refractory Crohn's disease were submitted to daily sessions of Hyperbaric Oxygen Therapy, in a 2800 Sechrist Monoplace Hyperbaric Chamber (Sechrist, USA) pressurized to 2.4 ATA. Each session lasted 2 hours. The endpoint was closure of enterocutaneous fistulas and complete healing of Pyoderma Gangrenosum and perineal Crohn's disease. RESULTS: A total of 829 HBOT sessions were performed and no complications were noted. Overall success rate was 76% (22 cases). Pyoderma Gangrenosum and enterocutaneous fistulas had the highest successful healing rates (100% and 91%, respectively). Perineal Crohn's disease healing rate was 65%. CONCLUSION: Adjunctive Hyperbaric Oxygen Therapy promoted satisfactory healing in a group of patients with refractory Crohn's disease.


Subject(s)
Humans , Male , Child , Adult , Middle Aged , Aged , Young Adult , Wound Healing , Crohn Disease/therapy , Intestinal Fistula/therapy , Pyoderma Gangrenosum/therapy , Hyperbaric Oxygenation/methods , Time Factors , Prospective Studies , Reproducibility of Results , Treatment Outcome , Combined Modality Therapy , Hyperbaric Oxygenation/statistics & numerical data
17.
J. appl. oral sci ; 23(2): 158-163, Mar-Apr/2015. tab, graf
Article in English | LILACS, BBO | ID: lil-746546

ABSTRACT

Phosphoric acid has been suggested as an irrigant due to its effectiveness in removing the smear layer. Objectives : The purpose of this study was to compare the antimicrobial and cytotoxic effects of a 37% phosphoric acid solution to other irrigants commonly used in endodontics. Material and Methods : The substances 37% phosphoric acid, 17% EDTA, 10% citric acid, 2% chlorhexidine (solution and gel), and 5.25% NaOCl were evaluated. The antimicrobial activity was tested against Candida albicans, Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Actinomyces meyeri, Parvimonas micra, Porphyromonas gingivalis, and Prevotella nigrescens according to the agar diffusion method. The cytotoxicity of the irrigants was determined by using the MTT assay. Results : Phosphoric acid presented higher antimicrobial activity compared to the other tested irrigants. With regard to the cell viability, this solution showed results similar to those with 5.25% NaOCl and 2% chlorhexidine (gel and solution), whereas 17% EDTA and 10% citric acid showed higher cell viability compared to other irrigants. Conclusion : Phosphoric acid demonstrated higher antimicrobial activity and cytotoxicity similar to that of 5.25% NaOCl and 2% chlorhexidine (gel and solution). .


Subject(s)
Humans , Male , Young Adult , Burns/etiology , Hyperbaric Oxygenation/methods , Iridium/adverse effects , Occupational Exposure/adverse effects , Radiation Injuries/therapy , Burns/physiopathology , Burns/therapy , Combined Modality Therapy , Follow-Up Studies , Hand Injuries/diagnosis , Hand Injuries/therapy , Injury Severity Score , Occupational Health , Radiation Injuries/diagnosis , Treatment Outcome , Wound Healing/physiology
18.
Acta cir. bras ; 30(4): 264-269, 04/2015. tab
Article in English | LILACS | ID: lil-744274

ABSTRACT

PURPOSE: To assess the mutagenic potential of the oxygen inhalation therapy (HBO), by means of the micronucleus test, performed in peripheral blood of rats that underwent subtotal splenectomy with lower pole preservation (ESTPI), after HBO sessions or simulations. METHODS: Eighteen male Wistar rats, were distributed into three groups of six animals: group 1 - submitted to ESTPI and HBO sessions; group 2 - submitted to ESTPI and HBO simulations; group 3 - underwent cyclophosphamide administration. In groups 1 and 2, blood samples from the animals' tails were collected before surgery (T0) and immediately after the 13th HBO session or simulation (T1). In group 3, tail blood samples were collected from animals before (T0) and 24 hours after (T1) cyclophosphamide (CP) delivery. The number of micronucleated normochromatic erythrocytes (MNNCE) was determined by blind counting 2000 normochromatic erythrocytes (NCE) per animal. RESULTS: Micronuclei average after CP delivery in group 3 was higher than before its use, thus confirming the mutagenic activity of this drug (p=0.01). In groups 1 and 2, no significant difference in the average of Micronuclei was observed when comparing it to blood samples before and after the 13th HBO session or simulation. CONCLUSION: The treatment protocol used in this study did not induce Micronucleus formation in animals submitted to ESTPI and HBO treatment or simulation. .


Subject(s)
Animals , Male , Hyperbaric Oxygenation/methods , Spleen/surgery , Splenectomy/methods , Cyclophosphamide/pharmacology , Micronucleus Tests , Mutagenicity Tests , Mutagens/pharmacology , Postoperative Period , Rats, Wistar , Time Factors , Treatment Outcome
19.
Acta cir. bras ; 30(4): 235-241, 04/2015. tab, graf
Article in English | LILACS | ID: lil-744275

ABSTRACT

PURPOSE: To evaluate the morphology, necrotic area and collagen content in skin flaps of rats subjected to hyperbaric oxygenation (HBO). METHODS: Forty adult rats were divided into four groups: GEC - epilated; GE/HBO - epilated subjected to HBO; GER - epilated submitted to skin flap (2 cm in width /8 cm length in the dorsal area) and GER/HBO - epilated, subjected to skin flap and HBO. HBO (2.4 ATA) was performed for two hours during seven consecutive days. In the eighth day, the rats were anesthetized and the skin flaps were removed and separated into three portions, relative to pedicle fixation. The material fixed in 10% formalin was processed for paraffin embedding; sections were stained by H.E and subjected to picrosirius-red method. The slides examined under light microscopy for evaluation of the collagen content in polarized light microscope and ImageLab(r) software (Bio-Rad). RESULTS: The data showed larger area of necrosis and lower levels of collagen in the three regions of the GER group, whereas in the GER/HBO group the collagen content was similar to the GEC and GE/HBO groups. CONCLUSION: Hyperbaric oxygenation reduced the area of necrosis and preserved the morphology and collagen content in skin flaps of rats. .


Subject(s)
Animals , Rats , Collagen/analysis , Hyperbaric Oxygenation/methods , Skin Transplantation/methods , Skin/pathology , Surgical Flaps/pathology , Surgical Flaps/physiology , Biopsy , Necrosis/pathology , Random Allocation , Reproducibility of Results , Time Factors , Treatment Outcome , Wound Healing
20.
Indian J Biochem Biophys ; 2015 Feb; 52 (1): 29-33
Article in English | IMSEAR | ID: sea-157952

ABSTRACT

Serum neuron-specific enolase (NSE) and S-100β levels are considered novel biochemical markers of neuronal cell injury. In this study, the initial and post-treatment levels of NSE and S-100β were compared in carbon monoxide (CO) poisoning patients, who received normorbaric oxygen (NBO) or hyperbaric oxygen (HBO) therapy. Forty consecutive patients with acute CO poisoning were enrolled in this prospective, observational study. According to their clinical symptoms and observations, twenty patients were treated with NBO, and the other twenty with HBO. Serum S-100β and NSE levels were measured both at time of admission and 6 h later (post-treatment). Serum NSE and S-100β values decreased significantly in both of the therapeutic modalities. The initial and post-treatment values of NSE and S-100β in NBO or HBO patients were comparable. A clear negative correlation was observed between the decrease of NSE and S-100β levels and initial blood carboxyhemoglobin levels. In conclusion, the present results suggested the use of serum S-100β and NSE levels as indicators for brain injury. Due to the significant increase of their values with oxygen therapy, they may also be useful as prognostic follow-up markers. However, the current findings reflected no difference between the efficacy of NBO or HBO therapy.


Subject(s)
Biomarkers , Brain Injuries , Carbon Monoxide Poisoning/epidemiology , Carbon Monoxide Poisoning/therapy , Humans , Hyperbaric Oxygenation/methods , Patients , Phosphopyruvate Hydratase/blood , S100 Calcium Binding Protein beta Subunit/blood , S100 Proteins/blood
SELECTION OF CITATIONS
SEARCH DETAIL